
A decade-long analysis of US poison control data reveals lidocaine-related fatalities increased from 67% to 82% of local anesthetic deaths between 2010-2022, with poisoning cases rising 50% from 2016-2021. This trend contradicts the overall 23% decline in local anesthetic poisonings following 2010 safety guidelines.
⚕️ Key Clinical Considerations ⚕️
- Mortality rates: Lidocaine poisoning resulted in 0.1% fatality rate versus 0.01% for other local anesthetics.
- Setting vulnerability: Deaths increasingly occur in outpatient facilities with inadequately trained staff.
- Dose miscalculation: Fatal cases involved administration errors, including 2% lidocaine instead of saline flush.
- Systemic toxicity: Local anesthetic systemic toxicity (LAST) affects CNS and cardiovascular systems causing seizures, arrhythmias.
- Detection challenges: Adverse events often attributed to other causes, suggesting significant underreporting.
🎯 Clinical Practice Impact 🎯
- Patient Communication: Educate patients about proper OTC lidocaine use and maximum dosing limits (300mg single adult dose).
- Practice Integration: Ensure lipid emulsion therapy availability and staff LAST recognition training in all settings using lidocaine.
- Risk Management: Implement dose verification protocols, especially for outpatient procedures requiring large lidocaine volumes.
- Action Items: Review current lidocaine storage practices and consider limiting large-volume preparations in non-hospital settings.
More in Anesthesiology
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS